Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BSG | P35613 | 1/20 | 0.47 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pseudolaric Acid A SCHEMBL27964349 | 1.00 | BSG (0.47) | BSGCRBN | |
| Pseudolaric Acid B SCHEMBL29367226 | 0.88 | BSG (0.58) | BSGCRBN | |
| Pseudolaric Acid B SCHEMBL29357444 | 0.88 | BSG (0.58) | BSGCRBN | |
| Pseudolaric Acid C SCHEMBL28774868 | 0.74 | BSG (0.46) | BSGCRBN | |
| Pseudolaric Acid C SCHEMBL29754805 | 0.74 | BSG (0.46) | BSGCRBN | |
| SCHEMBL28845305 | 0.73 | BSG (0.45) | BSGCRBN | |
| SCHEMBL29414444 | 0.55 | — | — | |
| SCHEMBL22880612 | 0.55 | — | — | |
| SCHEMBL29414445 | 0.55 | — | — | |
| Acetic Acid SCHEMBL16099584 | 0.54 | GLI1 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4642465-A1 | A CANCER ASSOCIATED FIBROBLAST (CAF) INHIBITOR FOR USE WITH AN ALTERNATING ELECTRIC FIELD IN A METHOD OF TREATING DISEASES SUCH AS CANCER | Novocure GmbH (CH) | 2025-11-05 | — | — | EP | disclosed |
| EP-4615869-A1 | COMBINATION THERAPY COMPRISING BISPECIFIC ANTIBODIES COMPRISING AN NRP1 BINDING DOMAIN | Pinetree Therapeutics, Inc. (US) | 2025-09-17 | — | — | EP | disclosed |
| WO-2024220483-A2 | GRP78 CHIMERIC ANTIGEN RECEPTORS AND COMBINATION THERAPIES FOR TREATING CANCER | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2024-10-24 | — | — | WO | disclosed |
| US-20240216403-A1 | METHODS AND COMPOSITIONS FOR INHIBITING FIBROBLAST ACTIVATION | BIOPHARMA CREDIT PLC (GB) | 2024-07-04 | — | — | US | disclosed |
| WO-2024141952-A1 | A CANCER ASSOCIATED FIBROBLAST (CAF) INHIBITOR FOR USE WITH AN ALTERNATING ELECTRIC FIELD IN A METHOD OF TREATING DISEASES SUCH AS CANCER | NOVOCURE GMBH (CH) | 2024-07-04 | — | — | WO | disclosed |
| WO-2024102187-A1 | COMBINATION THERAPY COMPRISING BISPECIFIC ANTIBODIES COMPRISING AN NRP1 BINDING DOMAIN | PINETREE THERAPEUTICS, INC. (US) | 2024-05-16 | — | — | WO | disclosed |
| US-20230046151-A1 | SYSTEM FOR PROVIDING CUSTOMIZED COSMETICS | LG HOUSEHOLD & HEALTH CARE LTD. (KR) | 2023-02-16 | — | — | US | disclosed |
| EP-4123553-A1 | SYSTEM FOR PROVIDING CUSTOMIZED COSMETICS | LG Household & Health Care Ltd. (KR) | 2023-01-25 | — | — | EP | disclosed |
| CN-115337339-A | Medicine for treating cardiovascular and cerebrovascular diseases and preparation method thereof | 西安天久肽健康科技有限公司 | 2022-11-15 | — | — | CN | disclosed |
| CN-114787851-A | Customized cosmetic providing system | 株式会社LG生活健康 | 2022-07-22 | — | — | CN | disclosed |
| CN-113133964-B | Multifunctional nail polish and preparation method thereof | 浙江珍珠生活科技有限公司 | 2022-06-14 | — | — | CN | disclosed |